Skip to content

Clinical trials

Completed Phase 3 Emphysema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emphysema Phase: Phase 3 Status: Completed Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20042
20053
20071
20094
20113
20121
20132

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Sumitomo Pharma America, Inc.3
GlaxoSmithKline2
National Heart, Lung, and Blood Institute (NHLBI)2
Asan Medical Center1
Emphasys Medical1
Temple University1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emphysema20
Pulmonary Disease, Chronic Obstructive20
Bronchitis, Chronic13
Bronchitis3
Bronchiolitis Obliterans Syndrome2
Lung Diseases, Obstructive2
Epstein-Barr Virus Infections1
Lung Diseases1
Pulmonary Emphysema1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.